Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:2193-2200
Published online before print May 1, 2006, doi: 10.1161/CIRCULATIONAHA.106.615401
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
113/18/2193    most recent
CIRCULATIONAHA.106.615401v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zee, R. Y.L.
Right arrow Articles by Ridker, P. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zee, R. Y.L.
Right arrow Articles by Ridker, P. M
Related Collections
Right arrow Risk Factors
Right arrow Deep vein thrombosis
Right arrow Epidemiology

(Circulation. 2006;113:2193-2200.)
© 2006 American Heart Association, Inc.


Genetics

Polymorphism in the ß2-Adrenergic Receptor and Lipoprotein Lipase Genes as Risk Determinants for Idiopathic Venous Thromboembolism

A Multilocus, Population-Based, Prospective Genetic Analysis

Robert Y.L. Zee, PhD; Nancy R. Cook, ScD; Suzanne Cheng, PhD; Henry A. Erlich, PhD; Klaus Lindpaintner, MD; Paul M Ridker, MD

From the Center for Cardiovascular Disease Prevention, Leducq Center for Molecular and Genetic Epidemiology, and Donald W. Reynolds Center for Cardiovascular Research, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (R.Y.L.Z., N.R.C., P.M.R.); Department of Human Genetics, Roche Molecular Systems, Alameda, Calif (S.C., H.A.E.); and Roche Center for Medical Genomics, Basel, Switzerland (K.L.).

Correspondence to Robert Y.L. Zee, BDS, MPH, PhD, Laboratory of Genetic and Molecular Epidemiology, Brigham and Women’s Hospital, Harvard Medical School, 900 Commonwealth Ave E, Boston, MA 02215. E-mail rzee{at}rics.bwh.harvard.edu

Received January 19, 2006; revision received March 8, 2006; accepted March 10, 2006.

Background— Candidate genes in inflammation, thrombosis, coagulation, and lipid metabolism pathways have been implicated in venous thromboembolism (VTE).

Methods and Results— Using DNA samples collected at baseline in the Physicians’ Health Study cohort, we genotyped 92 polymorphisms from 56 candidate genes among 304 individuals who subsequently developed VTE (144 idiopathic, 156 secondary cases) and among 2070 individuals who remained free of reported vascular disease over a mean follow-up of 13.2 years to prospectively determine whether these gene polymorphisms contribute to the risk of VTE. For idiopathic VTE, in addition to the factor V (Leiden) mutation (odds ratio [OR], 5.13; 95% confidence interval [CI], 3.24 to 8.14; P<0.0001; false discovery rate [FDR], P<0.0001), an N291S lipoprotein lipase gene polymorphism (OR, 3.09; 95% CI, 1.56 to 6.09; P=0.001; FDR, P=0.036) and a Q27E ß2-adrenergic receptor gene polymorphism (OR, 1.40; 95% CI, 1.09 to 1.79; P=0.006; FDR, P=0.036) were found to be significantly associated with increased risk. For secondary VTE, a Q360H apolipoprotein A4 gene polymorphism (OR, 0.34; 95% CI, 0.18 to 0.65; P=0.001; FDR, P=0.07) and an I50V interleukin-4 receptor polymorphism (OR, 0.66; 95% CI, 0.52 to 0.84; P=0.0009; FDR, P=0.07) were moderately, but not statistically and significantly, associated with reduced risk after adjustment for multiple comparisons.

Conclusions– These present findings are hypothesis generating and require replication and confirmation in an independent investigation.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Circ Cardiovasc GenetHome page
R. Y.L. Zee, R. J. Glynn, S. Cheng, L. Steiner, L. Rose, and P. M Ridker
An Evaluation of Candidate Genes of Inflammation and Thrombosis in Relation to the Risk of Venous Thromboembolism: The Women's Genome Health Study
Circ Cardiovasc Genet, February 1, 2009; 2(1): 57 - 62.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
L. Qi, N. Rifai, and F. B. Hu
Interleukin-6 Receptor Gene Variations, Plasma Interleukin-6 Levels, and Type 2 Diabetes in U.S. Women
Diabetes, December 1, 2007; 56(12): 3075 - 3081.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
N. L. Smith, L. A. Hindorff, S. R. Heckbert, R. N. Lemaitre, K. D. Marciante, K. Rice, T. Lumley, J. C. Bis, K. L. Wiggins, F. R. Rosendaal, et al.
Association of Genetic Variations With Nonfatal Venous Thrombosis in Postmenopausal Women
JAMA, February 7, 2007; 297(5): 489 - 498.
[Abstract] [Full Text] [PDF]